List of Tables
Table 1. Global Celiac Disease Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Celiac Disease Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Celiac Disease Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Celiac Disease Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Celiac Disease Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Celiac Disease Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Celiac Disease Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Celiac Disease Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Celiac Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Celiac Disease Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Celiac Disease Drug, Product Type & Application
Table 12. Global Key Manufacturers of Celiac Disease Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Celiac Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celiac Disease Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Celiac Disease Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Celiac Disease Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Celiac Disease Drug Sales Market Share by Region (2020-2025)
Table 19. Global Celiac Disease Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Celiac Disease Drug Sales Market Share by Region (2026-2031)
Table 21. Global Celiac Disease Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Celiac Disease Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Celiac Disease Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Celiac Disease Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Celiac Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Celiac Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Celiac Disease Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Celiac Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Celiac Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Celiac Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Celiac Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Celiac Disease Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Celiac Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Celiac Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Celiac Disease Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Celiac Disease Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Celiac Disease Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Celiac Disease Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Celiac Disease Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Celiac Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Celiac Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Celiac Disease Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Celiac Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Celiac Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Celiac Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Celiac Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Celiac Disease Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Celiac Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Celiac Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Celiac Disease Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Celiac Disease Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Celiac Disease Drug Sales Market Share by Type (2020-2025)
Table 53. Global Celiac Disease Drug Sales Market Share by Type (2026-2031)
Table 54. Global Celiac Disease Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Celiac Disease Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Celiac Disease Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Celiac Disease Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Celiac Disease Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Celiac Disease Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Celiac Disease Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Celiac Disease Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Celiac Disease Drug Sales Market Share by Application (2020-2025)
Table 63. Global Celiac Disease Drug Sales Market Share by Application (2026-2031)
Table 64. Global Celiac Disease Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Celiac Disease Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Celiac Disease Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Celiac Disease Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Celiac Disease Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Celiac Disease Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. F. Hoffmann-La Roche Company Information
Table 71. F. Hoffmann-La Roche Description and Business Overview
Table 72. F. Hoffmann-La Roche Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. F. Hoffmann-La Roche Celiac Disease Drug Product
Table 74. F. Hoffmann-La Roche Recent Developments/Updates
Table 75. Johnson & Johnson Company Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Johnson & Johnson Celiac Disease Drug Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Merck Celiac Disease Drug Product
Table 84. Merck Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Pfizer Celiac Disease Drug Product
Table 89. Pfizer Recent Developments/Updates
Table 90. ADMA Biologics Company Information
Table 91. ADMA Biologics Description and Business Overview
Table 92. ADMA Biologics Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. ADMA Biologics Celiac Disease Drug Product
Table 94. ADMA Biologics Recent Developments/Updates
Table 95. Amgen Company Information
Table 96. Amgen Description and Business Overview
Table 97. Amgen Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Amgen Celiac Disease Drug Product
Table 99. Amgen Recent Developments/Updates
Table 100. Anthera Pharmaceuticals Company Information
Table 101. Anthera Pharmaceuticals Description and Business Overview
Table 102. Anthera Pharmaceuticals Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Anthera Pharmaceuticals Celiac Disease Drug Product
Table 104. Anthera Pharmaceuticals Recent Developments/Updates
Table 105. Bayer Company Information
Table 106. Bayer Description and Business Overview
Table 107. Bayer Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Bayer Celiac Disease Drug Product
Table 109. Bayer Recent Developments/Updates
Table 110. Biogen Company Information
Table 111. Biogen Description and Business Overview
Table 112. Biogen Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Biogen Celiac Disease Drug Product
Table 114. Biogen Recent Developments/Updates
Table 115. BioLineRx Company Information
Table 116. BioLineRx Description and Business Overview
Table 117. BioLineRx Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. BioLineRx Celiac Disease Drug Product
Table 119. BioLineRx Recent Developments/Updates
Table 120. Biotest Company Information
Table 121. Biotest Description and Business Overview
Table 122. Biotest Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Biotest Celiac Disease Drug Product
Table 124. Biotest Recent Developments/Updates
Table 125. Bristol-Myers Squibb Company Information
Table 126. Bristol-Myers Squibb Description and Business Overview
Table 127. Bristol-Myers Squibb Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Bristol-Myers Squibb Celiac Disease Drug Product
Table 129. Bristol-Myers Squibb Recent Developments/Updates
Table 130. Celgene Company Information
Table 131. Celgene Description and Business Overview
Table 132. Celgene Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Celgene Celiac Disease Drug Product
Table 134. Celgene Recent Developments/Updates
Table 135. Takeda Pharmaceutical Company Information
Table 136. Takeda Pharmaceutical Description and Business Overview
Table 137. Takeda Pharmaceutical Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Takeda Pharmaceutical Celiac Disease Drug Product
Table 139. Takeda Pharmaceutical Recent Developments/Updates
Table 140. Novartis Company Information
Table 141. Novartis Description and Business Overview
Table 142. Novartis Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Novartis Celiac Disease Drug Product
Table 144. Novartis Recent Developments/Updates
Table 145. LFB Group Company Information
Table 146. LFB Group Description and Business Overview
Table 147. LFB Group Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. LFB Group Celiac Disease Drug Product
Table 149. LFB Group Recent Developments/Updates
Table 150. Kedrion Biopharma Company Information
Table 151. Kedrion Biopharma Description and Business Overview
Table 152. Kedrion Biopharma Celiac Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Kedrion Biopharma Celiac Disease Drug Product
Table 154. Kedrion Biopharma Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Celiac Disease Drug Distributors List
Table 158. Celiac Disease Drug Customers List
Table 159. Celiac Disease Drug Market Trends
Table 160. Celiac Disease Drug Market Drivers
Table 161. Celiac Disease Drug Market Challenges
Table 162. Celiac Disease Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Celiac Disease Drug
Figure 2. Global Celiac Disease Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Celiac Disease Drug Market Share by Type: 2024 & 2031
Figure 4. Distension Product Picture
Figure 5. Diarrhea Product Picture
Figure 6. Anorexia Product Picture
Figure 7. Others Product Picture
Figure 8. Global Celiac Disease Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Celiac Disease Drug Market Share by Application: 2024 & 2031
Figure 10. First Line of Treatment
Figure 11. Second Line of Treatment
Figure 12. Global Celiac Disease Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Celiac Disease Drug Market Size (2020-2031) & (US$ Million)
Figure 14. Global Celiac Disease Drug Sales (2020-2031) & (K Pcs)
Figure 15. Global Celiac Disease Drug Average Price (USD/Pcs) & (2020-2031)
Figure 16. Celiac Disease Drug Report Years Considered
Figure 17. Celiac Disease Drug Sales Share by Manufacturers in 2024
Figure 18. Global Celiac Disease Drug Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Celiac Disease Drug Players: Market Share by Revenue in Celiac Disease Drug in 2024
Figure 20. Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Celiac Disease Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Celiac Disease Drug Sales Market Share by Country (2020-2031)
Figure 23. North America Celiac Disease Drug Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Celiac Disease Drug Sales Market Share by Country (2020-2031)
Figure 27. Europe Celiac Disease Drug Revenue Market Share by Country (2020-2031)
Figure 28. Germany Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Celiac Disease Drug Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Celiac Disease Drug Revenue Market Share by Region (2020-2031)
Figure 35. China Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Celiac Disease Drug Sales Market Share by Country (2020-2031)
Figure 46. Latin America Celiac Disease Drug Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Celiac Disease Drug Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Celiac Disease Drug Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Celiac Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Celiac Disease Drug by Type (2020-2031)
Figure 56. Global Revenue Market Share of Celiac Disease Drug by Type (2020-2031)
Figure 57. Global Celiac Disease Drug Price (USD/Pcs) by Type (2020-2031)
Figure 58. Global Sales Market Share of Celiac Disease Drug by Application (2020-2031)
Figure 59. Global Revenue Market Share of Celiac Disease Drug by Application (2020-2031)
Figure 60. Global Celiac Disease Drug Price (USD/Pcs) by Application (2020-2031)
Figure 61. Celiac Disease Drug Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
